Publication | Open Access
Mild progressive multifocal leukoencephalopathy after switching from natalizumab to ocrelizumab
25
Citations
6
References
2020
Year
The clinical course of carryover PML was mild in both patients, suggesting that B-cell depletion possibly did not aggravate PML-IRIS in these 2 patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1